Loading…
Loading grant details…
| Funder | NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES |
|---|---|
| Recipient Organization | Florida Atlantic University |
| Country | United States |
| Start Date | Sep 01, 2022 |
| End Date | Aug 30, 2025 |
| Duration | 1,094 days |
| Number of Grantees | 2 |
| Roles | Principal Investigator; Co-Investigator |
| Data Source | NIH (US) |
| Grant ID | 10796611 |
Abstract Cholesterol (Chol) plays a key role for neuronal functionality and survival, the disruption of cellular Chol homeostasis has been linked to major neurodegenerative disorders including Parkinson’s disease, Huntington’s disease, and Alzheimer’s disease (AD). Cholesterol not only modifies the trafficking and cleavage of amyloid
precursor protein (APP) but also worsens the aggregation of β-amyloid peptides (Aβs) and Tau protein. Moreover, abnormality of membrane-embedded cholesterol can cause synaptic dysfunction by impairing the turnover of synaptic vesicles (SVs) and the activities of postsynaptic receptors. While the vast majority studies
have been focused on Chol’s cellular metabolism, more and more reports have suggested that intracellular Chol transport via membrane trafficking or newly discovered sterol transporters provides more local control of subcellular membrane cholesterol distribution than the global regulation of cholesterol metabolism. Studying
cholesterol transport, especially in live cells, requires fluorescent probes and imaging capability that can not only mimic membrane cholesterol but also distinguish the plasma membrane and intracellular compartments like endosomes. In this project we propose to develop a class of environment-sensitive fluorescent Chol probes
(CNDs) using 1,8-naphthalimide fluorophore and use them to elucidate the subcellular distribution and trafficking of Chol as well as its implication in AD pathogenesis. We will take a multidisciplinary strategy with advanced technologies including computational chemistry, chemical synthesis and live-cell imaging. Based on the modular
scaffold of our proposed probes, we will generate new CNDs with different properties. We will determine the uptake, distribution, and dispersion of selected CNDs in different cell types (3T3 fibroblast cells, astrocytes, and neurons) and different subcellular compartments (e.g., different organelles including endosomes, lysosomes and
lipid droplets) with high spatiotemporal precision. To study CNDs’ resemblance to endogenous Chol, we will ask how disrupting cellular processes and activity of proteins involved in Chol uptake, intracellular transport, sequestration, and dispersion will affect CNDs staining. Combining selected CNDs with spectrally separable
reporters for synaptic vesicles (SVs) and APP, we will study how Chol in different membrane compartments affect SV turnover, APP distribution and cleavage in major types of brain cells. Using transgenic methods, we will ask how APP and its major cleavage product affect mChol trafficking and homeostasis. Using
pharmacological inhibitors, we will ask how the secretase cleavages of APP affect mChol. Furthermore, we will ask how such altered mChol regulation associates with synaptic dysfunction and neuronal loss commonly found in AD. In summary, this project will rejuvenate the studies of membrane Chol and give the participating students
an interdisciplinary research experience.
Florida Atlantic University
Complete our application form to express your interest and we'll guide you through the process.
Apply for This Grant